How the OcuSurf Nanocore Delivery System Targets Blepharitis with a Dual-Drug Ophthalmic Formulation
The Challenge: Treating Blepharitis and the Absence of Approved Ophthalmic Therapy Blepharitis is a chronic inflammation of the eyelids in which the eyelids become red,
June 12, 2026
No Comments